Search

everythinglearnresearchcommunity

for

Search:↓

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

A patient developed a blister at the injection site after hepatitis C treatment.

Targeting specific T cells may help treat alopecia areata.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Blocking interferon-gamma might help treat various autoimmune diseases.

A man lost all his hair as a rare side effect after hepatitis C treatment.

ILC1 cells contribute to hair loss in alopecia areata.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Combination therapies might work better for some vitiligo patients, but results vary.

Nail loss may be a side effect of the MS drug teriflunomide.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Skin ulcers from interferon may not depend on the amount given.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.